Development of the optimal composition of tablets with the active substance potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate. Message 1. Study of the effect of auxiliary substances on bulk density, bulk density after shrinkage, fluidity and angle of natural slope of powder masses
The pharmaceutical industry continually evolves to meet the demands of modern society for high-quality medications. One avenue of this advancement involves exploring new technologies for manufacturing tablet formulations that adhere to contemporary quality standards. An integral aspect of this proce...
Saved in:
| Main Authors: | R. O. Shcherbyna, O. V. Khromylova, H. R. Nimenko, V. O. Salionov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2024-06-01
|
| Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| Subjects: | |
| Online Access: | http://pharmed.zsmu.edu.ua/article/view/300704/297769 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The choice of auxiliary substances to obtain sublingual glycin tablets with thiotriazoline with direct compaction method Reporting 1. Study of the influence of excipients on the bulk density, the bulk density after shrinkage, the fluidity and the angle o
by: L. I. Kucherenko, et al.
Published: (2020-05-01) -
Histological study of potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazole-3-yl)thio)acetate (PKR-173) corrective influence on the chickens liver state in the condition of tetracycline hepatitis
by: R. O. Shcherbyna, et al.
Published: (2018-06-01) -
Determination of the isotonicity 1 % solution of sodium 2-((4-amino-5-thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)acetate
by: D. L. Usenko, et al.
Published: (2024-02-01) -
The research of ammonium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazole-3-yl)thio)acetate (PKR-177) influence on biochemical indices in rats blood under hepatitis initiated by tetrachloride methane
by: R. О. Shcherbyna, et al.
Published: (2017-12-01) -
The research on creation the dosage form based on 3-(4-nitrophenyl)-5-(nonylsulfonyl)-1,2,4-triazol-4-amine
by: M. A. Shcherbak, et al.
Published: (2014-08-01)